| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 20 | 2025 | 729 | 1.890 |
Why?
|
| Adenocarcinoma | 9 | 2025 | 1014 | 1.000 |
Why?
|
| Genome, Human | 9 | 2025 | 1331 | 0.760 |
Why?
|
| Sequence Analysis, DNA | 7 | 2021 | 1799 | 0.750 |
Why?
|
| Transplants | 1 | 2021 | 36 | 0.700 |
Why?
|
| Biomarkers, Tumor | 7 | 2025 | 1658 | 0.650 |
Why?
|
| Mutation | 13 | 2025 | 6229 | 0.630 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2025 | 169 | 0.610 |
Why?
|
| Receptors, Somatostatin | 4 | 2011 | 54 | 0.590 |
Why?
|
| Organ Transplantation | 1 | 2021 | 180 | 0.590 |
Why?
|
| Ampulla of Vater | 3 | 2025 | 17 | 0.580 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 212 | 0.580 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 26 | 0.480 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2016 | 58 | 0.470 |
Why?
|
| Common Bile Duct Neoplasms | 2 | 2025 | 10 | 0.460 |
Why?
|
| Bile Duct Neoplasms | 3 | 2023 | 124 | 0.450 |
Why?
|
| Cholangiocarcinoma | 3 | 2023 | 123 | 0.450 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 205 | 0.440 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2016 | 20 | 0.430 |
Why?
|
| Gene Expression Profiling | 5 | 2015 | 1882 | 0.400 |
Why?
|
| Genomics | 7 | 2025 | 1647 | 0.350 |
Why?
|
| DNA-Binding Proteins | 4 | 2022 | 1977 | 0.330 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2014 | 985 | 0.310 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 48 | 0.300 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2015 | 175 | 0.300 |
Why?
|
| Liver Neoplasms | 5 | 2017 | 1381 | 0.300 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2021 | 38 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2020 | 2057 | 0.290 |
Why?
|
| Genetic Techniques | 1 | 2009 | 103 | 0.290 |
Why?
|
| Transcription Factors | 4 | 2017 | 2493 | 0.290 |
Why?
|
| Gene Library | 1 | 2009 | 213 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2011 | 2849 | 0.280 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2022 | 72 | 0.270 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 254 | 0.270 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2020 | 490 | 0.260 |
Why?
|
| Tissue Banks | 3 | 2011 | 30 | 0.250 |
Why?
|
| Pain Threshold | 1 | 2006 | 21 | 0.250 |
Why?
|
| Base Sequence | 9 | 2017 | 2899 | 0.240 |
Why?
|
| Homeodomain Proteins | 5 | 2016 | 575 | 0.240 |
Why?
|
| Humans | 55 | 2025 | 132061 | 0.240 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2006 | 39 | 0.240 |
Why?
|
| Laminin | 1 | 2006 | 72 | 0.240 |
Why?
|
| Neoplasm Proteins | 4 | 2009 | 697 | 0.240 |
Why?
|
| Trans-Activators | 5 | 2016 | 712 | 0.230 |
Why?
|
| Nerve Regeneration | 1 | 2006 | 85 | 0.230 |
Why?
|
| Strepsirhini | 1 | 2025 | 2 | 0.230 |
Why?
|
| RNA, Messenger | 11 | 2017 | 2674 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2015 | 613 | 0.230 |
Why?
|
| Precision Medicine | 3 | 2015 | 360 | 0.230 |
Why?
|
| Intellectual Disability | 3 | 2022 | 1087 | 0.230 |
Why?
|
| Integrins | 5 | 2016 | 91 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2021 | 3350 | 0.220 |
Why?
|
| Cell Line, Tumor | 12 | 2025 | 3681 | 0.220 |
Why?
|
| Tissue Engineering | 1 | 2006 | 168 | 0.210 |
Why?
|
| Antigens, CD | 3 | 2001 | 431 | 0.210 |
Why?
|
| U937 Cells | 2 | 2001 | 23 | 0.210 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 3770 | 0.210 |
Why?
|
| Gene Flow | 1 | 2023 | 15 | 0.200 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 824 | 0.200 |
Why?
|
| Papio | 1 | 2023 | 60 | 0.200 |
Why?
|
| Receptors, Cell Surface | 4 | 2009 | 450 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 7 | 2012 | 1548 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2002 | 550 | 0.200 |
Why?
|
| Fibroblasts | 3 | 2006 | 861 | 0.200 |
Why?
|
| Monocytes | 2 | 2002 | 342 | 0.200 |
Why?
|
| Skin | 1 | 2006 | 537 | 0.190 |
Why?
|
| Neoplasms | 3 | 2016 | 2955 | 0.190 |
Why?
|
| Databases, Genetic | 3 | 2016 | 501 | 0.190 |
Why?
|
| Genes, Neoplasm | 2 | 2016 | 86 | 0.190 |
Why?
|
| Lung Neoplasms | 7 | 2015 | 1538 | 0.190 |
Why?
|
| Biological Evolution | 1 | 2023 | 243 | 0.180 |
Why?
|
| Proteomics | 1 | 2006 | 596 | 0.180 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 147 | 0.180 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 70 | 0.180 |
Why?
|
| Membrane Glycoproteins | 2 | 2002 | 420 | 0.180 |
Why?
|
| Receptors, IgE | 1 | 2001 | 11 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 333 | 0.180 |
Why?
|
| Antigens, CD20 | 1 | 2001 | 40 | 0.180 |
Why?
|
| Glioblastoma | 2 | 1995 | 363 | 0.170 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 126 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2023 | 235 | 0.170 |
Why?
|
| INDEL Mutation | 1 | 2021 | 92 | 0.170 |
Why?
|
| Cell Movement | 4 | 2020 | 889 | 0.170 |
Why?
|
| Genotype | 3 | 2011 | 2697 | 0.170 |
Why?
|
| Animals | 31 | 2025 | 34881 | 0.170 |
Why?
|
| Prognosis | 5 | 2025 | 5009 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 540 | 0.170 |
Why?
|
| DNA, Neoplasm | 2 | 2016 | 295 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 37 | 0.160 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2005 | 814 | 0.160 |
Why?
|
| Genes, Dominant | 1 | 2020 | 250 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 3 | 1995 | 233 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 387 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2021 | 225 | 0.150 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2016 | 26 | 0.150 |
Why?
|
| Transfection | 7 | 2010 | 996 | 0.150 |
Why?
|
| Patient Selection | 2 | 2020 | 737 | 0.150 |
Why?
|
| Mice | 22 | 2016 | 18507 | 0.150 |
Why?
|
| DNA Methylation | 3 | 2021 | 1122 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 233 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2020 | 454 | 0.140 |
Why?
|
| Abnormalities, Multiple | 2 | 2022 | 981 | 0.140 |
Why?
|
| Endothelium, Vascular | 3 | 1997 | 487 | 0.140 |
Why?
|
| Male | 19 | 2025 | 64920 | 0.140 |
Why?
|
| Tissue Donors | 1 | 2021 | 504 | 0.140 |
Why?
|
| Biopsy | 1 | 2021 | 1284 | 0.140 |
Why?
|
| Genetic Testing | 2 | 2021 | 1098 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 560 | 0.130 |
Why?
|
| Adenovirus E3 Proteins | 1 | 1996 | 3 | 0.130 |
Why?
|
| Islets of Langerhans | 3 | 2012 | 163 | 0.120 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 76 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 2669 | 0.120 |
Why?
|
| Cardiology | 1 | 2021 | 498 | 0.120 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2015 | 5 | 0.120 |
Why?
|
| Caenorhabditis elegans | 2 | 2015 | 243 | 0.120 |
Why?
|
| Osmoregulation | 1 | 2015 | 2 | 0.120 |
Why?
|
| Integrin alpha5beta1 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 97 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2009 | 454 | 0.120 |
Why?
|
| Glycogen | 1 | 2015 | 53 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 79 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2006 | 3036 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 753 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 1995 | 1378 | 0.120 |
Why?
|
| Endosomes | 1 | 2015 | 65 | 0.120 |
Why?
|
| Macrophages | 1 | 2000 | 689 | 0.120 |
Why?
|
| Cell Line | 6 | 2014 | 2719 | 0.120 |
Why?
|
| Neutrophils | 1 | 1997 | 361 | 0.110 |
Why?
|
| Gene Expression | 1 | 2000 | 1558 | 0.110 |
Why?
|
| Microsatellite Repeats | 1 | 2016 | 236 | 0.110 |
Why?
|
| Gluconeogenesis | 1 | 2015 | 96 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 921 | 0.110 |
Why?
|
| Female | 15 | 2025 | 70710 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2015 | 172 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 1995 | 116 | 0.110 |
Why?
|
| Oncogenes | 4 | 2010 | 175 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2009 | 651 | 0.110 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 266 | 0.110 |
Why?
|
| Cell Proliferation | 7 | 2023 | 2508 | 0.110 |
Why?
|
| Estrone | 1 | 2014 | 12 | 0.110 |
Why?
|
| Fibrosarcoma | 3 | 1990 | 26 | 0.110 |
Why?
|
| Spermatozoa | 1 | 1996 | 243 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2016 | 245 | 0.110 |
Why?
|
| Mice, Nude | 3 | 2016 | 752 | 0.110 |
Why?
|
| Phenotype | 6 | 2023 | 4529 | 0.100 |
Why?
|
| Adult | 6 | 2025 | 31567 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 1044 | 0.100 |
Why?
|
| Genes, ras | 2 | 1990 | 100 | 0.100 |
Why?
|
| Membrane Proteins | 4 | 2020 | 1610 | 0.100 |
Why?
|
| Middle Aged | 5 | 2025 | 28964 | 0.100 |
Why?
|
| RNA Interference | 2 | 2012 | 514 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 662 | 0.100 |
Why?
|
| Insulinoma | 1 | 2012 | 8 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2014 | 209 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 396 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 1996 | 925 | 0.090 |
Why?
|
| Pedigree | 3 | 2025 | 1719 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 63 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2012 | 174 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2003 | 311 | 0.090 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 33 | 0.090 |
Why?
|
| Glucose | 3 | 2023 | 878 | 0.090 |
Why?
|
| Histone Acetyltransferases | 1 | 2012 | 227 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 59 | 0.090 |
Why?
|
| Somatostatin | 1 | 2011 | 62 | 0.090 |
Why?
|
| Neoplasm Metastasis | 3 | 1990 | 719 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 1284 | 0.080 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 1996 | 140 | 0.080 |
Why?
|
| Autophagy | 1 | 2014 | 426 | 0.080 |
Why?
|
| Patient Care | 1 | 2011 | 99 | 0.080 |
Why?
|
| DNA | 1 | 1996 | 1473 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 199 | 0.080 |
Why?
|
| Epigenomics | 3 | 2021 | 191 | 0.080 |
Why?
|
| Dystonic Disorders | 1 | 2011 | 94 | 0.080 |
Why?
|
| Endopeptidases | 1 | 1990 | 114 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 7102 | 0.080 |
Why?
|
| Urogenital Abnormalities | 1 | 2012 | 164 | 0.080 |
Why?
|
| Genome | 1 | 2012 | 503 | 0.080 |
Why?
|
| Axons | 1 | 2012 | 390 | 0.080 |
Why?
|
| Inteins | 1 | 2009 | 3 | 0.080 |
Why?
|
| Cytokines | 1 | 1995 | 1358 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2002 | 1960 | 0.080 |
Why?
|
| DNA Primers | 2 | 2003 | 636 | 0.080 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 57 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2014 | 633 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 803 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 1990 | 238 | 0.080 |
Why?
|
| Catalysis | 1 | 2009 | 138 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 71 | 0.070 |
Why?
|
| Risk | 1 | 2011 | 760 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2092 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 296 | 0.070 |
Why?
|
| ras Proteins | 1 | 2009 | 146 | 0.070 |
Why?
|
| Kinetics | 2 | 2009 | 1130 | 0.070 |
Why?
|
| Pharmacogenetics | 2 | 2021 | 200 | 0.070 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 1280 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 1454 | 0.060 |
Why?
|
| Young Adult | 1 | 2021 | 9956 | 0.060 |
Why?
|
| Aged | 4 | 2025 | 21406 | 0.060 |
Why?
|
| Alleles | 1 | 2011 | 1686 | 0.060 |
Why?
|
| Liver | 6 | 2017 | 1797 | 0.060 |
Why?
|
| Exons | 1 | 2009 | 805 | 0.060 |
Why?
|
| Skin, Artificial | 1 | 2006 | 8 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 1694 | 0.060 |
Why?
|
| Mitochondria | 3 | 2017 | 747 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2010 | 876 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2012 | 382 | 0.060 |
Why?
|
| Adolescent | 3 | 2021 | 20562 | 0.060 |
Why?
|
| Smoking | 1 | 2011 | 938 | 0.060 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 604 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2005 | 66 | 0.060 |
Why?
|
| Papio anubis | 1 | 2025 | 4 | 0.060 |
Why?
|
| Madagascar | 1 | 2025 | 8 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1824 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2012 | 601 | 0.060 |
Why?
|
| Apoptosis | 3 | 2014 | 1892 | 0.060 |
Why?
|
| Mutation Rate | 1 | 2025 | 72 | 0.060 |
Why?
|
| alpha-Fetoproteins | 4 | 1988 | 134 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2025 | 391 | 0.050 |
Why?
|
| Signal Transduction | 4 | 2015 | 4703 | 0.050 |
Why?
|
| Subtraction Technique | 1 | 2003 | 36 | 0.050 |
Why?
|
| Exome | 3 | 2014 | 1087 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 327 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2023 | 62 | 0.050 |
Why?
|
| Baclofen | 1 | 2023 | 45 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 136 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 445 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2016 | 358 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2023 | 105 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 20 | 0.050 |
Why?
|
| Integrin beta1 | 3 | 1997 | 56 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2003 | 3418 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 43 | 0.050 |
Why?
|
| Species Specificity | 1 | 2023 | 541 | 0.050 |
Why?
|
| Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Wound Healing | 1 | 2006 | 477 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 518 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 84 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 225 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 123 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2021 | 38 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 45 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 811 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2002 | 94 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2023 | 327 | 0.040 |
Why?
|
| Acetyltransferases | 2 | 2000 | 77 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 1045 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 2 | 2011 | 73 | 0.040 |
Why?
|
| Leukemia, Myeloid | 1 | 2001 | 81 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 56 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 383 | 0.040 |
Why?
|
| Phylogeny | 1 | 2023 | 764 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 4757 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2021 | 246 | 0.040 |
Why?
|
| Mediator Complex | 1 | 2020 | 63 | 0.040 |
Why?
|
| Independent Living | 1 | 2020 | 70 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 300 | 0.040 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2000 | 54 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 163 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2002 | 358 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 213 | 0.040 |
Why?
|
| Pancreas | 2 | 2012 | 222 | 0.040 |
Why?
|
| Forecasting | 2 | 2011 | 372 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 17419 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2000 | 252 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 105 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2016 | 763 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 1280 | 0.040 |
Why?
|
| United States | 4 | 2021 | 11658 | 0.040 |
Why?
|
| Protein Transport | 2 | 2015 | 369 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2002 | 595 | 0.040 |
Why?
|
| Leukemia | 1 | 2002 | 370 | 0.040 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 1995 | 12 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 632 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 1998 | 46 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1996 | 123 | 0.040 |
Why?
|
| Running | 1 | 1998 | 33 | 0.040 |
Why?
|
| Acute Disease | 1 | 2001 | 1160 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 624 | 0.040 |
Why?
|
| Integrin alpha6beta1 | 1 | 1997 | 2 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1997 | 8 | 0.030 |
Why?
|
| Reference Values | 2 | 1998 | 708 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 1997 | 28 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2000 | 363 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 687 | 0.030 |
Why?
|
| Family | 1 | 2020 | 596 | 0.030 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2017 | 37 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 2017 | 30 | 0.030 |
Why?
|
| Plasmids | 2 | 1996 | 459 | 0.030 |
Why?
|
| Insulin | 2 | 2012 | 1168 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2017 | 65 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 1422 | 0.030 |
Why?
|
| Salmon | 1 | 1996 | 5 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1997 | 210 | 0.030 |
Why?
|
| Hemizygote | 1 | 2016 | 13 | 0.030 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1996 | 31 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1996 | 18 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 117 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2016 | 4 | 0.030 |
Why?
|
| Thymidine Kinase | 1 | 1996 | 90 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2016 | 26 | 0.030 |
Why?
|
| Prolactin | 1 | 1996 | 113 | 0.030 |
Why?
|
| Phosphoenolpyruvate | 1 | 2015 | 2 | 0.030 |
Why?
|
| Glycogen Phosphorylase | 1 | 2015 | 1 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 261 | 0.030 |
Why?
|
| Glycogen Synthase | 1 | 2015 | 7 | 0.030 |
Why?
|
| Access to Information | 1 | 2016 | 45 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 93 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2016 | 44 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 56 | 0.030 |
Why?
|
| Th2 Cells | 1 | 1996 | 188 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2015 | 157 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 158 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2015 | 46 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 2015 | 38 | 0.030 |
Why?
|
| Proteins | 2 | 2012 | 1036 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 17 | 0.030 |
Why?
|
| CD58 Antigens | 1 | 1995 | 7 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 113 | 0.030 |
Why?
|
| Telomere | 1 | 2017 | 222 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2320 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 357 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2146 | 0.030 |
Why?
|
| Cricetinae | 1 | 2015 | 381 | 0.030 |
Why?
|
| Dexamethasone | 3 | 1988 | 276 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 1995 | 62 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 129 | 0.030 |
Why?
|
| Disease Progression | 2 | 2011 | 2224 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 207 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 166 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 451 | 0.030 |
Why?
|
| Genes | 2 | 1988 | 313 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 368 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2014 | 19 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1996 | 731 | 0.030 |
Why?
|
| Birt-Hogg-Dube Syndrome | 1 | 2014 | 5 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 13028 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 157 | 0.030 |
Why?
|
| Glutamine | 1 | 2015 | 211 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 44 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 158 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 589 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 240 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 1988 | 2438 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 271 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2014 | 179 | 0.030 |
Why?
|
| Telomerase | 1 | 2014 | 168 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 865 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 1131 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 141 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 3863 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2016 | 201 | 0.030 |
Why?
|
| Chromatin | 1 | 2017 | 518 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 323 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 565 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 373 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 385 | 0.030 |
Why?
|
| CpG Islands | 1 | 2014 | 343 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 275 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1995 | 678 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2014 | 272 | 0.020 |
Why?
|
| Risk Factors | 2 | 2005 | 10941 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 613 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 124 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1573 | 0.020 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2012 | 17 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 492 | 0.020 |
Why?
|
| Blepharophimosis | 1 | 2012 | 26 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2012 | 57 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1988 | 59 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 207 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 480 | 0.020 |
Why?
|
| Bone Diseases, Developmental | 1 | 2012 | 60 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 1033 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 1046 | 0.020 |
Why?
|
| Codon | 1 | 2011 | 98 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 114 | 0.020 |
Why?
|
| Glioma | 1 | 1996 | 529 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1729 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1032 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 46 | 0.020 |
Why?
|
| Blepharoptosis | 1 | 2012 | 70 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 94 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 449 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 133 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 808 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 230 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1131 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1995 | 1047 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 749 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 713 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2009 | 14 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2009 | 21 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2009 | 20 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 1125 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1988 | 20 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 785 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 123 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2020 | 14751 | 0.020 |
Why?
|
| Growth Substances | 1 | 1988 | 109 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 424 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 3014 | 0.020 |
Why?
|
| Confidentiality | 1 | 2009 | 106 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1988 | 47 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2009 | 149 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 611 | 0.020 |
Why?
|
| Cerebellum | 1 | 2012 | 462 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2010 | 799 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 271 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 257 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1728 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3629 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1990 | 473 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 677 | 0.020 |
Why?
|
| Informed Consent | 1 | 2009 | 347 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1988 | 291 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1996 | 41 | 0.020 |
Why?
|
| Decision Making | 1 | 2011 | 700 | 0.020 |
Why?
|
| Lymphokines | 2 | 1996 | 66 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 1028 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1987 | 347 | 0.010 |
Why?
|
| Fetus | 1 | 1988 | 593 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 1297 | 0.010 |
Why?
|
| Child | 2 | 2020 | 25789 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 898 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1828 | 0.010 |
Why?
|
| Computational Biology | 1 | 2009 | 875 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 2658 | 0.010 |
Why?
|
| Hormones | 1 | 1983 | 170 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 143 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 83 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 1470 | 0.010 |
Why?
|
| Prednisolone | 1 | 1981 | 73 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 150 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 4688 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 301 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 365 | 0.010 |
Why?
|
| Transcriptional Activation | 2 | 1995 | 429 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 367 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1866 | 0.010 |
Why?
|
| Time Factors | 1 | 1990 | 6448 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 470 | 0.010 |
Why?
|
| Rats | 4 | 1988 | 3611 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1990 | 118 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 762 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1998 | 64 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 139 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1608 | 0.010 |
Why?
|
| Lewis X Antigen | 1 | 1996 | 11 | 0.010 |
Why?
|
| L-Selectin | 1 | 1996 | 19 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 33 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 1443 | 0.010 |
Why?
|
| Albumins | 2 | 1988 | 95 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1998 | 506 | 0.010 |
Why?
|
| Integrin alpha1beta1 | 1 | 1994 | 4 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1995 | 342 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 249 | 0.010 |
Why?
|
| DNA Replication | 2 | 1988 | 353 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1990 | 161 | 0.000 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1990 | 106 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1988 | 35 | 0.000 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1988 | 45 | 0.000 |
Why?
|
| Tyrosine Transaminase | 1 | 1988 | 6 | 0.000 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1988 | 63 | 0.000 |
Why?
|
| Epidermal Growth Factor | 1 | 1988 | 118 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1988 | 98 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1990 | 331 | 0.000 |
Why?
|
| Cytosol | 1 | 1988 | 144 | 0.000 |
Why?
|
| Fibroblast Growth Factors | 1 | 1988 | 166 | 0.000 |
Why?
|
| Lung | 1 | 1994 | 1559 | 0.000 |
Why?
|
| Medroxyprogesterone | 1 | 1983 | 8 | 0.000 |
Why?
|
| Methionine | 1 | 1983 | 102 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1981 | 219 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1981 | 116 | 0.000 |
Why?
|